Montelukast Intermediate Market Overview The Montelukast Intermediate Market is estimated to be valued at USD 4,794.763 thousand by 2023 and Expected to register CAGR of 4.34% During the Forecast Period. The Global Montelukast Intermediate Market has been evaluated as a moderately growing market, and it is expected that the market will continue to grow similarly in the near future. Factors characterizing the market growth are worldwide rising prevalence of asthma, bronchospasm, allergic rhinitis, and urticaria, burgeoning pharmaceutical industry coupled with the increasing demand from API manufacturers, and montelukast patent expiration along with the increasing presence of generics. burgeoning pharmaceutical industry coupled with the increasing demand from active pharmaceutical ingredients (APIs) manufacturers, and montelukast patent expiration along with the increasing presence of generics. All the major players are competing with each other to capture a major stake of the...